Summary and Future Directions Although multiple PG assays have been developed to assess abnormal fibrinolysis in bleeding or thrombotic diseases, the (patho)physiological effects of plasmin in many diseases is still unclear. focuses on their Mouse monoclonal to WDR5 applications in defining the role of plasmin in diseases, including angioedema, hemophilia, rare bleeding disorders, COVID-19, or […]